Holen Sie sich die Stockscreener-App
4.1799
10.49%
-0.4901
Schlusskurs vom Vortag:
$4.67
Offen:
$4.69
24-Stunden-Volumen:
1.75M
Relative Volume:
1.57
Marktkapitalisierung:
$251.26M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-33.85M
KGV:
-7.4138
EPS:
-0.5638
Netto-Cashflow:
$-33.35M
1W Leistung:
-12.92%
1M Leistung:
-20.83%
6M Leistung:
-22.45%
1J Leistung:
-38.62%
1-Tages-Spanne:
$4.01
$4.72
1-Wochen-Bereich:
$4.01
$5.60
52-Wochen-Spanne:
$1.14
$7.08
Aldeyra Therapeutics Inc Stock (ALDX) Company Profile
Firmenname
Aldeyra Therapeutics Inc
Sektor
Branche
Telefon
781-761-4904
Adresse
131 HARTWELL AVENUE, LEXINGTON, MA
Compare ALDX vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ALDX
Aldeyra Therapeutics Inc
|
4.175 | 281.05M | 0 | -33.85M | -33.35M | -0.5638 |
|
VRTX
Vertex Pharmaceuticals Inc
|
472.28 | 121.46B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
743.73 | 78.93B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
695.77 | 43.87B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.53 | 42.07B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
284.50 | 31.65B | 5.36B | 287.73M | 924.18M | 2.5229 |
Aldeyra Therapeutics Inc Stock (ALDX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-04-03 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2024-04-02 | Fortgesetzt | H.C. Wainwright | Buy |
| 2022-04-27 | Fortgesetzt | H.C. Wainwright | Buy |
| 2021-02-08 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-12-16 | Eingeleitet | Berenberg | Buy |
| 2020-10-30 | Eingeleitet | Jefferies | Buy |
| 2020-10-16 | Eingeleitet | BTIG Research | Buy |
| 2020-09-22 | Eingeleitet | Alliance Global Partners | Buy |
| 2020-05-12 | Eingeleitet | Oppenheimer | Outperform |
| 2018-12-04 | Eingeleitet | Citigroup | Buy |
| 2018-09-26 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2018-09-13 | Eingeleitet | Janney | Buy |
| 2018-01-26 | Eingeleitet | Seaport Global Securities | Buy |
| 2016-09-26 | Eingeleitet | H.C. Wainwright | Buy |
| 2016-07-01 | Eingeleitet | Stifel | Buy |
| 2015-07-01 | Eingeleitet | Canaccord Genuity | Buy |
| 2015-03-25 | Eingeleitet | Chardan Capital Markets | Buy |
| 2015-03-20 | Bestätigt | H.C. Wainwright | Buy |
| 2014-11-18 | Eingeleitet | H.C. Wainwright | Buy |
| 2014-06-19 | Eingeleitet | Aegis Capital | Buy |
Alle ansehen
Aldeyra Therapeutics Inc Aktie (ALDX) Neueste Nachrichten
ALDX stock garners retail interest: Investors debate dry eye treatment approval amid long wait - MSN
ALDX Stock Garners Retail Interest: Investors Debate Dry Eye Treatment Approval Amid Long Wait - Stocktwits
Aldeyra Therapeutics: Investor Attention Shifts to Upcoming Catalysts - AD HOC NEWS
Movement Recap: Does Aldeyra Therapeutics Inc have a sustainable dividend2025 Trade Ideas & Community Verified Trade Alerts - baoquankhu1.vn
HC Wainwright Analysts Boost Earnings Estimates for ALDX - MarketBeat
HC Wainwright Issues Pessimistic Estimate for ALDX Earnings - MarketBeat
Aldeyra Therapeutics (NASDAQ:ALDX) Shares Cross Below 200-Day Moving AverageHere's What Happened - MarketBeat
How volatile is Aldeyra Therapeutics Inc. stock2025 Technical Overview & Community Verified Watchlist Alerts - mfd.ru
EBITDA per share of Aldeyra Therapeutics, Inc. – DUS:137 - TradingView
Why (ALDX) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Aldeyra Therapeutics (NASDAQ: ALDX) outlines reproxalap, ADX-2191 and AbbVie deal - Stock Titan
Aldeyra Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Published on: 2026-02-28 16:42:08 - baoquankhu1.vn
Aldeyra Therapeutics, Inc. SEC 10-K Report - TradingView
Coya Therapeutics, Inc. (COYA) upgraded to buy: What does it mean for the stock? - MSN
Aldeyra Therapeutics, Inc.Common Stock (NQ: ALDX - The Chronicle-Journal
Is Aldeyra Therapeutics (ALDX) Outperforming Other Medical Stocks This Year? - Yahoo Finance
Is Aldeyra Therapeutics (ALDX) Surpassing Other Healthcare Stocks in Performance This Year? - Bitget
Aldeyra Therapeutics CEO Highlights Reproxalap Ahead of March 16 FDA Decision at Oppenheimer Conference - MarketBeat
Overview of FDA Regulatory Developments - Intellectia AI
Aldeyra Therapeutics Inc expected to post a loss of 17 cents a shareEarnings Preview - TradingView
Aldeyra Therapeutics (ALDX) Expected to Announce Quarterly Earnings on Friday - MarketBeat
Understanding Momentum Shifts in (ALDX) - Stock Traders Daily
Does Aldeyra Therapeutics (ALDX) Have the Potential to Rally 79.28% as Wall Street Analysts Expect? - Zacks Investment Research
Aldeyra Therapeutics (NASDAQ:ALDX) Stock Passes Below 200-Day Moving AverageHere's What Happened - MarketBeat
Aldeyra Therapeutics to Participate in the Oppenheimer 36th Annual Healthcare Life Sciences Conference - marketscreener.com
Biotech CEO in fireside chat at Oppenheimer health conference - Stock Titan
Perceptive fund discloses 7% Aldeyra (ALDX) ownership stake - Stock Titan
Biotech Stocks Facing FDA Decision In March 2026 - RTTNews
Does Aldeyra Therapeutics Inc. have a sustainable dividendJuly 2025 Reactions & Daily Profit Maximizing Tips - mfd.ru
Aldeyra's Dry Eye Therapy Faces FDA In MarchWill The Third Time Be A Charm? - RTTNews
Published on: 2026-02-12 20:14:42 - baoquankhu1.vn
Aldeyra Therapeutics (NASDAQ:ALDX) Stock Price Passes Above 50 Day Moving AverageShould You Sell? - MarketBeat
Avoiding Lag: Real-Time Signals in (ALDX) Movement - Stock Traders Daily
Wall Street analysts predict a 65.75% upside in Aldeyra Therapeutics (ALDX): Here's what you should know - MSN
Wall Street Analysts Predict a 65.75% Upside in Aldeyra Therapeutics (ALDX): Here's What You Should Know - Finviz
Aldeyra Shares Climb on FDA Backing for PVRL Drug Trial Design - MSN
Are Medical Stocks Lagging Aldeyra Therapeutics (ALDX) This Year? - Yahoo Finance
Aldeyra’s Dry Eye Drug Faces A Make-Or-Break FDA Call - Finimize
PFG Investments LLC Reduces Stock Position in Aldeyra Therapeutics, Inc. $ALDX - MarketBeat
Discipline and Rules-Based Execution in ALDX Response - Stock Traders Daily
Aldeyra Therapeutics (NASDAQ:ALDX) Share Price Crosses Above Fifty Day Moving AverageHere's Why - MarketBeat
Earnings Recap: Is Aldeyra Therapeutics Inc exposed to political riskQuarterly Risk Review & Low Risk Profit Maximizing Plans - baoquankhu1.vn
Market Review: Does Aldeyra Therapeutics Inc have consistent dividend growthJuly 2025 Action & Low Volatility Stock Recommendations - baoquankhu1.vn
Will BOOT benefit from green energy policies2025 Fundamental Recap & Low Volatility Stock Recommendations - baoquankhu1.vn
Aldeyra Therapeutics, Inc. (ALDX) Investigation: Bronstein, Gewir - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Is Investigating Aldeyra Thera - The National Law Review
ATA Creativity Global Among 3 Promising Penny Stocks - Yahoo Finance
Following a 4.3% decline over last year, recent gains may please Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) institutional owners - simplywall.st
Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) Short Interest Update - MarketBeat
Behavioral Patterns of ALDX and Institutional Flows - Stock Traders Daily
Finanzdaten der Aldeyra Therapeutics Inc-Aktie (ALDX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):